Literature DB >> 9625312

Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.

S Naveau1, D Emilie, A Balian, L Grangeot-Keros, E Borotto, A Portier, V Giraud, F Capron, P Galanaud, J C Chaput.   

Abstract

BACKGROUND/AIMS: Correlations between serum levels of soluble tumor necrosis factor receptors p55 (TNFsRp55) and Child Pugh index have previously been reported in alcoholic patients with cirrhosis. We have undertaken this study to improve understanding of the role of tumor necrosis factor soluble receptors (TNFsRs) in alcoholic liver disease.
METHODS: One hundred and two patients with alcoholic liver disease of various severity (23 pure steatosis, 22 fibrosis, seven acute alcoholic hepatitis without cirrhosis, 12 cirrhosis without acute alcoholic hepatitis, 14 cirrhosis with mild acute alcoholic hepatitis and 24 cirrhosis with severe acute alcoholic hepatitis) were studied. Blood was collected on EDTA and plasma was tested for TNFsR concentrations using ELISA assays.
RESULTS: Plasma levels of TNFsRp55 and p75 increased progressively with the severity of liver disease, reaching a maximum in cirrhotic patients with severe acute alcoholic hepatitis. Plasma levels of TNFsRp55 in patients with fibrosis and of TNFsRp75 in patients with acute alcoholic hepatitis without cirrhosis were already higher than in healthy controls. In cirrhotic patients with or without acute alcoholic hepatitis TNFsRp55 and p75 were significantly increased compared with controls. In cirrhotic patients, plasma levels of TNFsRp55 correlated positively with all parameters of liver injury, whereas the TNFsRp75/ TNFsRp55 ratio correlated negatively. In cirrhotic patients with severe acute alcoholic hepatitis, the TNFsRp75/TNFsRp55 ratio was significantly lower than in all other groups. In cirrhotic patients with severe acute alcoholic hepatitis treated by prednisolone, the decrease in TNFsRp55 plasma levels between day 1 and day 15 was significantly more important in patients still alive at 2 months than in patients who died within 2 months.
CONCLUSIONS: These results show that the expression of TNF-soluble receptors (TNFsRs) participates in the early phases of the alcoholic liver disease and that the TNFsRp75/TNFsRp55 ratio and plasma levels of TNFsRp55 may help to determine the diagnosis and the prognosis of severe acute alcoholic hepatitis in cirrhotics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625312     DOI: 10.1016/s0168-8278(98)80227-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model.

Authors:  Chiung-Kuei Huang; Tunan Yu; Suzanne M de la Monte; Jack R Wands; Zoltan Derdak; Miran Kim
Journal:  J Hepatol       Date:  2015-02-24       Impact factor: 25.083

2.  Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis.

Authors:  C Hanck; T Manigold; U Böcker; M Kurimoto; C B Kölbel; M V Singer; S Rossol
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 3.  Alcoholic liver disease: mechanisms of injury and targeted treatment.

Authors:  Alexandre Louvet; Philippe Mathurin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

4.  Predicting mortality by the Glasgow alcoholic hepatitis score: the long awaited progress?

Authors:  H Tilg; A Kaser
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

5.  TNFalpha is required for cholestasis-induced liver fibrosis in the mouse.

Authors:  Erwin Gäbele; Matthias Froh; Gavin E Arteel; Takehiko Uesugi; Claus Hellerbrand; Jürgen Schölmerich; David A Brenner; Ronald G Thurman; Richard A Rippe
Journal:  Biochem Biophys Res Commun       Date:  2008-11-06       Impact factor: 3.575

6.  Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

Authors:  R P Mookerjee; S Sen; N A Davies; S J Hodges; R Williams; R Jalan
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

7.  Toll-like receptors in the pathogenesis of alcoholic liver disease.

Authors:  Jan Petrasek; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Gastroenterol Res Pract       Date:  2010-08-17       Impact factor: 2.260

Review 8.  Cellular and molecular mechanisms of liver injury.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

9.  Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension.

Authors:  Jonel Trebicka; Aleksander Krag; Stefan Gansweid; Peter Schiedermaier; Holger M Strunk; Rolf Fimmers; Christian P Strassburg; Fleming Bendtsen; Søren Møller; Tilman Sauerbruch; Ulrich Spengler
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

10.  Combined Intraperitoneal and Intrathecal Etanercept Reduce Increased Brain Tumor Necrosis Factor-Alpha and Asymmetric Dimethylarginine Levels and Rescues Spatial Deficits in Young Rats after Bile Duct Ligation.

Authors:  Jiunn-Ming Sheen; Yu-Chieh Chen; Mei-Hsin Hsu; You-Lin Tain; Hong-Ren Yu; Li-Tung Huang
Journal:  Front Cell Neurosci       Date:  2016-06-23       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.